In recent years, the cannabis industry has witnessed a surge in interest surrounding Delta-8 THC. While Delta-9 THC is more well-known for its psychoactive effects, Delta-8 THC has gained attention for its potential health benefits, particularly in reducing inflammation within the body.
Delta-8 THC, or tetrahydrocannabinol, is one of over 100 cannabinoids found in the cannabis plant. It shares a nearly identical molecular structure with Delta-9 THC, but has double bonds between it's 8th carbon atoms (D-8) rather than it's 9th carbon atoms (D-9). Delta-8 THC is reported to offer a milder, more manageable high, making it an attractive option for those seeking therapeutic effects without the intensity associated with its counterpart.
Several studies have explored the potential anti-inflammatory properties of cannabinoids, including Delta-8 THC. A study published in the journal "Biochemical Pharmacology" in 2018 found that cannabinoids, including Delta-8 THC, demonstrated anti-inflammatory effects by modulating cytokine production and immune cell activity. Cytokines are signaling molecules that play a crucial role in the body's inflammatory response, and the modulation of these molecules can impact inflammation levels.
Furthermore, a 2020 review published in the "International Journal of Molecular Sciences" emphasized the immunomodulatory effects of cannabinoids, suggesting that Delta-8 THC may contribute to the regulation of immune responses, potentially leading to reduced inflammation. The study highlighted the need for further research to fully understand the mechanisms involved.
A more recent study published by the University of South Carolina in July, 2021, revealed the effects that the endocannabinoid receptors of the brain play in controlling bodily inflammation. This study found that both Delta-8 and Delta-9 THC molecules bind to the CB2 receptor of the brain, helping to suppress inflammation by decreasing the inflammation response of immune cells. This finding suggests that Delta-8 THC is preferrable over Delta-9 in suppressing body inflammation, because it is less psychoactive.
While the research on Delta-8 THC is still in its early stages, there is promising evidence suggesting that this cannabinoid may indeed have anti-inflammatory properties. The modulation of cytokines and immune cell activity showcased in various studies indicates the potential for Delta-8 THC to play a role in managing inflammation within the body.
As is always the case with discussing the health benefits of cannabis/hemp products, more research is needed to fully understand the mechanisms and implications of Delta-8 THC on inflammation. However, as our understanding of cannabinoids continues to evolve, the potential for Delta-8 THC as a therapeutic option for inflammation holds exciting possibilities for the future.